Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
0.176
0.00 (-0.06%)
At close: Nov 20, 2024, 4:00 PM
0.180
+0.004 (2.04%)
After-hours: Nov 20, 2024, 7:39 PM EST
Aclarion Employees
As of December 31, 2023, Aclarion had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$8,215
Profits / Employee
-$1,044,784
Market Cap
1.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| iCoreConnect | 70 |
| Sonnet BioTherapeutics Holdings | 12 |
| Tivic Health Systems | 9 |
| Shuttle Pharmaceuticals Holdings | 8 |
| Dermata Therapeutics | 8 |
| Allarity Therapeutics | 6 |
| GRI Bio | 4 |
| IMAC Holdings | 4 |
ACON News
- 6 days ago - Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st - Accesswire
- 6 weeks ago - Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 7 weeks ago - Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - GlobeNewsWire
- 2 months ago - PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology - GlobeNewsWire
- 2 months ago - Aclarion Provides Corporate Update on Nociscan AI Technology Milestones - GlobeNewsWire
- 2 months ago - Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial - GlobeNewsWire
- 2 months ago - Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market - GlobeNewsWire
- 3 months ago - Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey - GlobeNewsWire